These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30459211)

  • 1. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.
    Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ
    Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.
    Stagaard R; Flick MJ; Bojko B; Goryński K; Goryńska PZ; Ley CD; Olsen LH; Knudsen T
    J Thromb Haemost; 2018 Jul; 16(7):1369-1382. PubMed ID: 29758126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
    Rode F; Almholt K; Petersen M; Kreilgaard M; Kjalke M; Karpf DM; Groth AV; Johansen PB; Larsen LF; Loftager M; Haaning J
    J Thromb Haemost; 2018 Jun; 16(6):1141-1152. PubMed ID: 29582559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.
    Bugge TH; Kombrinck KW; Flick MJ; Daugherty CC; Danton MJ; Degen JL
    Cell; 1996 Nov; 87(4):709-19. PubMed ID: 8929539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain.
    Hultman K; Cortes-Canteli M; Bounoutas A; Richards AT; Strickland S; Norris EH
    J Thromb Haemost; 2014 May; 12(5):701-12. PubMed ID: 24612416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.
    Ploplis VA; Carmeliet P; Vazirzadeh S; Van Vlaenderen I; Moons L; Plow EF; Collen D
    Circulation; 1995 Nov; 92(9):2585-93. PubMed ID: 7586361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding.
    Wyseure T; Yang T; Zhou JY; Cooke EJ; Wanko B; Olmer M; Agashe R; Morodomi Y; Behrendt N; Lotz M; Morser J; von Drygalski A; Mosnier LO
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.
    Gong J; Yang R; Zhou M; Chang LJ
    Mol Med; 2023 Jun; 29(1):74. PubMed ID: 37308845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
    Bugge TH; Flick MJ; Daugherty CC; Degen JL
    Genes Dev; 1995 Apr; 9(7):794-807. PubMed ID: 7705657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia.
    Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Nielsen LV; Johansen PB; Hermit MB; Petersen LC; Mast AE
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3927-31. PubMed ID: 22355108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII.
    Chen H; Shi M; Gilam A; Zheng Q; Zhang Y; Afrikanova I; Li J; Gluzman Z; Jiang R; Kong LJ; Chen-Tsai RY
    Sci Rep; 2019 Nov; 9(1):16838. PubMed ID: 31727959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice.
    Cheng Q; Zhao Y; Lawson WE; Polosukhin VV; Johnson JE; Blackwell TS; Gailani D
    Blood; 2005 Nov; 106(9):3055-7. PubMed ID: 15985536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.
    Wang X; Shin SC; Chiang AF; Khan I; Pan D; Rawlings DJ; Miao CH
    Mol Ther; 2015 Apr; 23(4):617-26. PubMed ID: 25655313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
    Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
    Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro.
    Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A
    Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout mice.
    Bloem E; Karpf DM; Nørby PL; Johansen PB; Loftager M; Rahbek-Nielsen H; Petersen HH; Blouse GE; Thim L; Kjalke M; Bolt G
    J Thromb Haemost; 2019 Feb; 17(2):350-360. PubMed ID: 30525289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate(®)).
    Pastoft AE; Lykkesfeldt J; Ezban M; Tranholm M; Whinna HC; Lauritzen B
    Haemophilia; 2012 Sep; 18(5):782-8. PubMed ID: 22500820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.